*001940087
*00520230310100355.0
*007cr
*007ta
*008150827s1980    no#           000 0 eng d
*00901388cam a2200385 c 4500
*015  $a8003506$2nbf
*019  $bl
*035  $a(EXLNZ-47BIBSYS_NETWORK)998120450414702201
*035  $a(NO-LaBS)14354627(bibid)
*035  $a(NO-TrBIB)102661286
*035  $a(NO-TrBIB)812045041
*035  $a812045041-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*044  $cno
*060 4$aWB 330
*080  $a615.2
*08274$a615$qNO-OsNB$23/nor
*1001 $aBaksaas, Ingebjørg$0(NO-TrBIB)90139626$_119099200
*24510$aDrug utilization studies :$bat overall, prescription and patient levels$cby Ingebjørg Baksaas
*260  $aOslo$b[Forfatteren]$c1980
*300  $a412 s.$bill.
*4901 $aWHO technical report series$v615
*500  $aDr. avh. Universitetet i Oslo.
*500  $aPå tittelbl.: From the Division of Clinical Pharmacology and Toxicology, the Central Laboratory, Ullevål Hospital, Oslo, Norway.
*533  $aElektronisk reproduksjon$b[Norge]$cNasjonalbiblioteket Digital$d2008-06-05
*650 2$aAcademic Medical Centers$_23442500
*650 2$aDrug Utilization$_28118300
*650 2$aPharmaceutical preparations$_13842400
*830 0$aWHO technical report series$v615$_119099300
*85641$3Fulltekst$uhttps://urn.nb.no/URN:NBN:no-nb_digibok_2008060504038$yNettbiblioteket$zDigital representasjon
*901  $a80
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:998120450414702202$b2021-11-14T21:08:17Z$z998120450414702202
^